Lahore, 13th July: The US drug regulator, Food and Drug Administration (FDA), has issued a new warning to Johnson & Johnson vaccine used against the coronavirus.
The Food and Drug Administration has warned that with Johnson & Johnson’s COVID-19 vaccine, there is an increased risk of a rare neurological disorder in the six weeks after inoculation.
Data collected in this regard suggests that the Johnson & Johnson vaccine doses carry chances of getting Guillain-Barré syndrome (GBS).
BREAKING: FDA warns Johnson & Johnson coronavirus vaccine associated with increased risk of developing Guillain-Barre syndrome, in which the immune system attacks the nervous system.
— The Spectator Index (@spectatorindex) July 12, 2021
Therefore, J&J vaccine recipients should seek medical attention if they have symptoms including weakness or tingling sensations, difficulty walking or difficulty with facial movements.
Around 12.8 million people have received J&J’s one-dose vaccine in the United States.
According to the French news agency AFP, after reviewing the report of the Vaccine Safety Monitoring Agency, the authorities have confirmed that 100 people who were vaccinated with J&J have been diagnosed with Guillain-Barre Syndrome.
Of those, 95 are in critical condition and need to be hospitalized, with one death reported.
It is to be noted that GBS is a neurological disease in which the body’s immune system damages nerve cells which can lead to muscle weakness and in many serious cases paralysis. Most cases follow a bacterial or viral infection.
Hence, FDA’s warning is a setback for the J&J vaccine shot, as it was supposed to be an important tool for vaccinating in hard-to-reach areas. It may be noted that J&J requires only one shot and has less stringent storage requirements than the Pfizer or Moderna vaccines.
Meanwhile, the use of this vaccine has already been linked to a very rare, life-threatening blood clotting condition.
It is pertinent to mention here that last week, European regulators recommended a similar warning for AstraZeneca’s COVID-19 shot, which is based on the same technology as Johnson & Johnson’s vaccine.
Read all the latest and trending news on Baaghi TV!
Fears of a fourth wave have led to the release of a Delta variant
